{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:26:43Z","timestamp":1783114003101,"version":"3.54.6"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T00:00:00Z","timestamp":1388620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0084358","type":"journal-article","created":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T21:39:51Z","timestamp":1388698791000},"page":"e84358","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["Antagonism of Bradykinin B2 Receptor Prevents Inflammatory Responses in Human Endothelial Cells by Quenching the NF-kB Pathway Activation"],"prefix":"10.1371","volume":"9","author":[{"given":"Erika","family":"Terzuoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Meini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Catalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Cialdai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Alberto","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Giachetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Ziche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Donnini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,1,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/ncomms2199","article-title":"Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo","volume":"3","author":"F Orsenigo","year":"2012","journal-title":"Nat Commun"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bbrc.2011.10.137","article-title":"Bradykinin receptor 2 extends inflammatory cell recruitment in a model of acute gouty arthritis","volume":"416","author":"OM Shaw","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0006-2952(97)00186-X","article-title":"Bradykinin Antagonists in human systems: correlation between receptor binding, calcium signalling in isolated cells, and functional activity in isolated ileum","volume":"54","author":"M Wieczorek","year":"1997","journal-title":"Biochemical Pharmacology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/sj.bjp.0701943","article-title":"B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects","volume":"124","author":"L Morbidelli","year":"1998","journal-title":"Br J Pharmacol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1096\/fj.00-0503fje","article-title":"The bradykinin\/B1 receptor promotes angiogenesis by up-regulation of endogenous FGF-2 in endothelium via the nitric oxide synthase pathway","volume":"15","author":"A Parenti","year":"2001","journal-title":"FASEB J"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/PL00000307","article-title":"B1 and B2 antagonists and bradykinin-induced blood flow in rat skin inflammation","volume":"51","author":"T Cao","year":"2002","journal-title":"Inflamm Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1586\/eci.12.67","article-title":"Clinical efficacy of icatibant in the treatment of acute hereditary angioedema during the FAST-3 trial","volume":"8","author":"M Bas","year":"2012","journal-title":"Expert Rev Clin Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0162-3109(97)00023-4","article-title":"Generation of kinins in synovial fluid from patients with arthropathy","volume":"36","author":"AP Bond","year":"1997","journal-title":"Immunopharmacol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00011-007-7204-1","article-title":"Knee osteoarthritis: a role for bradykinin","volume":"57","author":"S Meini","year":"2008","journal-title":"Inflamm Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1111\/j.1476-5381.2009.00511.x","article-title":"Novel effects mediated by bradykinin and pharmacological characterization of bradykinin B2 receptor antagonism in human synovial fibroblasts","volume":"158","author":"F Bellucci","year":"2009","journal-title":"Br J Pharmacol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1476-5381.2010.01062.x","article-title":"Bradykinin and B(2) receptor antagonism in rat and human articular chondrocytes","volume":"162","author":"S Meini","year":"2011","journal-title":"Br J Pharmacol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/pr.57.1.2","article-title":"International union of pharmacology XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences","volume":"57","author":"LM Leeb-Lundberg","year":"2005","journal-title":"Pharmacol Rev"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1517\/13543770902994389","article-title":"Bradykinin receptor antagonists-a review of the patent literature 2005\u20132008","volume":"19","author":"CI Fincham","year":"2009","journal-title":"Expert Opin Ther Pat"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1517\/14656566.2012.723692","article-title":"Icatibant, the bradykinin B2 receptor antagonist with target to the interconnected kinin systems","volume":"13","author":"D Charignon","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejphar.2005.10.014","article-title":"MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization","volume":"528","author":"P Cucchi","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.bjp.0706995","article-title":"Comparative antagonist pharmacology at the native mouse bradykinin B2 receptor: radioligand binding and smooth muscle contractility studies","volume":"150","author":"S Meini","year":"2007","journal-title":"Br J Pharmacol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2009.04.057","article-title":"Pharmacological characterization of the bradykinin B2 receptor antagonist MEN16132 in rat in vitro bioassays","volume":"615","author":"S Meini","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejphar.2010.03.012","article-title":"Radioligand binding characterization of the bradykinin B(2) receptor in the rabbit and pig ileal smooth muscle","volume":"635","author":"S Meini","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ejphar.2007.10.025","article-title":"MEN16132, a kinin B2 receptor antagonist, prevents the endogenous bradykinin effects in guinea-pig airways","volume":"579","author":"C Valenti","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/j.1476-5381.2010.00995.x","article-title":"Anti-inflammatory synergy of MEN16132, a kinin B2 receptor antagonist, and dexamethasone in carrageenan-induced knee joint arthritis in rats","volume":"161","author":"C Valenti","year":"2010","journal-title":"Br J Pharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1124\/jpet.109.159657","article-title":"Effect of Intra-articular4-(S)-amino-5-(4-{4-[2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfo namido]-tetrahydro-2H-4-pyranylcarbonyl} piperazino)-5-oxopentyl](trimethyl)ammonium chloride hydrochloride (MEN16132), a kinin B2 receptor antagonist, on nociceptive response in monosodium iodoacetate-induced experimental osteoarthritis in rats","volume":"331","author":"C Cialdai","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.joca.2013.03.013","article-title":"Blockade of nociceptive sensory afferent activity of the rat knee joint by the bradykinin B2 receptor antagonist fasitibant","volume":"21","author":"A Gomis","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"ref23","first-page":"1054","article-title":"Angiogenesis: a therapeutic target in arthritis","volume":"2","author":"DA Walsh","year":"2001","journal-title":"Curr Opin Investig Drugs"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/art.11094","article-title":"Inflammation and angiogenesis in osteoarthritis","volume":"48","author":"L Haywood","year":"2003","journal-title":"Arthritis Rheum"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.joca.2007.01.020","article-title":"Angiogenesis in the synovium and at the osteochondral junction in osteoarthritis","volume":"15","author":"DA Walsh","year":"2007","journal-title":"Osteoarthritis Cartilage"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"P Carmeliet","year":"2000","journal-title":"Nature"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1161\/CIRCRESAHA.110.236786","article-title":"Tissue kallikrein is essential for invasive capacity of circulating proangiogenic cells","volume":"108","author":"G Spinetti","year":"2011","journal-title":"Circ Res"},{"key":"ref28","first-page":"1279","article-title":"Wound healing following myocardial infarction in the rat: role for bradykinin and prostaglandins. J. Mol. Cell Cardiol","volume":"28","author":"Cde Frimm","year":"1996"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nature03987","article-title":"Pathophysiological consequences of VEGF-induced vascular permeability","volume":"437","author":"SM Weis","year":"2005","journal-title":"Nature"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/ncb1752","article-title":"Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5","volume":"10","author":"A Taddei","year":"2008","journal-title":"Nat Cell Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nri2171","article-title":"Evolving functions of endothelial cells in inflammation","volume":"7","author":"JS Pober","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/CIRCRESAHA.109.203760","article-title":"Prostaglandin E(2) primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathway","volume":"105","author":"F Finetti","year":"2009","journal-title":"Circ Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/j.1476-5381.2010.01133.x","article-title":"Comparison of the molecular interactions of two antagonists, MEN16132 or icatibant, at the human kinin B2 receptor","volume":"162","author":"S Meini","year":"2011","journal-title":"Br J Pharmacol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","article-title":"Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases","volume":"336","author":"PJ Barnes","year":"1997","journal-title":"N Engl J Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","article-title":"NF-kappa B: a key role in inflammatory diseases","volume":"107","author":"PP Tak","year":"2001","journal-title":"J Clin Invest"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1161\/CIRCULATIONAHA.112.119321","article-title":"Endothelial nuclear factor-\u03baB-dependent regulation of arteriogenesis and branching","volume":"126","author":"D Tirziu","year":"2012","journal-title":"Circulation"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0022-3565(24)36453-5","article-title":"Different B1 kinin receptor expression and pharmacology in endothelial cells of different origins and species","volume":"280","author":"P Wohlfart","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1096\/fj.09-146456","article-title":"Abeta peptides accelerate the senescence of endothelial cells in vitro and in vivo, impairing angiogenesis","volume":"24","author":"S Donnini","year":"2010","journal-title":"FASEB J"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0084358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T10:38:41Z","timestamp":1746095921000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0084358"}},"subtitle":[],"editor":[{"given":"Costanza","family":"Emanueli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,2]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0084358","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,2]]}}}